Medline Anesthesia Trays Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medline Industries is recalling 1100 kits containing Huons Bupivacaine HCL in Dextrose Injection due to quality issues with the included drug.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on June 23, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Medical Devices.
What Happened
Medline Industries, LP distributed kits containing Huons Co. Bupivacaine Hydrochloride in Dextrose Injection, USP, which was subsequently recalled due to quality issues, including microbiology testing data integrity concerns and reported efficacy complaints. The recall is classified as Class I.
Which Products Are Affected
- ANESTHESIA TRAY, Medline SKU DYNJRA1355A (UDI/DI 10195327179830), lot numbers: 26CBA272, 26ABS307, 25HBE663, 25FBA408, 25CBG043, 24FBT395
- SPINAL ANESTHESIA TRAY, Medline SKU DYNJRA2151 (UDI/DI 10195327365400), lot number: 24FBT396 1100 kits distributed nationwide in the US, US Virgin Islands, Bahamas, Panama, and Barbados. Recall number Z-2231-2026.
What You Should Do
Check affected lot numbers and contact the recalling firm for further instructions.
Why This Matters
This Class I recall involves spinal and anesthesia kits distributed worldwide that contain a drug product with potential quality and efficacy issues.
Source
FDA recall Z-2231-2026
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,012 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to June 23, 2026.
Frequently Asked Questions
Common questions about this FDA recall.